IL10 and B-cell chronic lymphocytic leukemia: In CLL patients, a macrophage population acquires a pro-tumor phenotype driven by the CLL cells themselves through the secretion of soluble factors (e.g., IL-10, adenosine, and nicotinamide phosphoribosyl transferase) [50].